Eli Lilly is investing $1.8 billion to expand production in Ireland of its Alzheimer's treatment and weight-loss drugs. The company's Alzheimer's drug, Kisunla, was approved by the U.S. Food and ...

Eli Lilly and Company has announced a significant expansion of its manufacturing presence in Ireland, with a $1bn investment earmarked for its Limerick site. The move is aimed at boosting the ...

Driven by new product successes and strategic investments, Eli Lilly and Co (LLY) reports a 42% revenue increase, setting a ...

(Reuters) -Eli Lilly missed Wall Street estimates for third-quarter profit on Wednesday, hurt by higher manufacturing costs ...

Eli Lilly has added $1 billion to its investment plan for a new manufacturing facility in Ireland that will be used to produce its Alzheimer's therapy donanemab. The facility at a business park in ...

Eli Lilly has said it is seeking permission to build a new biopharmaceutical manufacturing facility in Ireland that will be used to produce active ingredients for its biologic medicines ...

In September of this year, management announced another $1.8 billion worth of projects split between two different parts of Ireland. At this point in time, Eli Lilly and Company is doing a ...

Lilly Limerick is set to be the global pharmaceutical leader's most technically advanced manufacturing site to date ...

Get Our Latest Stock Analysis on LLY Eli Lilly and Company Stock Up 0.1 % Shares of LLY opened at $917.18 on Friday. Eli Lilly and Company has a 12 month low of $547.61 and a 12 month high of $972 ...

EBGLYSS works Eli Lilly and Company (NYSE: LLY) today announced a $1 billion expansion of its Limerick, Ireland, manufacturing site to increase production of biologic active ingredients ...

Eli Lilly’s blockbuster weight loss and diabetes drugs missed analysts’ expectations by 18% in the third quarter, which were ...

Eli Lilly (LLY) stock is trading near its all-time ... They announced a $1.8 billion expansion of their factory in Ireland to increase production of key ingredients and keep their supply chain ...